As manyÂ as one-third of cadaveric kidney transplant recipients suffer graft loss within five years of transplantation.

Unfortunately, changes in immunotherapy have proven to be mostly ineffective in changing the prognosis for patients with established chronic allograft nephropathy.

Prevention, early diagnosis, management of both comorbidity, and complications of chronic kidney disease can improve the survival of patients with transplant failure.